Navigation Links
Manchester College Receives $35 Million Grant From Lilly Endowment for School of Pharmacy
Date:12/20/2010

FORT WAYNE, Ind., Dec. 20, 2010 /PRNewswire/ -- A small Midwest college that is producing alumni with sizeable reputations in the science world has received a $35 million grant from Lilly Endowment to launch a School of Pharmacy.

Manchester College, located in northern Indiana, has a Nobel Laureate in chemistry, the inventor of Teflon®, the discoverer of acid rain in North America and the first female commissioner of the U.S. Food and Drug Administration among its graduates.

The grant – the largest in Manchester College history – will help the liberal arts and sciences college develop its first doctoral program on a Fort Wayne campus, surrounded by regional hospitals, pharmacies and health care facilities and services.

Speaking on behalf of Lilly Endowment, Sara B. Cobb, vice president of education, said, "We are pleased to offer this funding to Manchester College to assist it in establishing its new School of Pharmacy. The school will further important efforts in Indiana to increase opportunities for education and careers in the STEM (science, technology, engineering, mathematics) disciplines. The Endowment believes this support should add significantly to the intellectual capital in Northeast Indiana and enhance the vibrant life sciences sector growing throughout the state."

Responding to the national shortage of pharmacists and openings in pharmacy schools, Manchester announced last fall its plans to seek accreditation for a four-year doctoral program in pharmacy, with the first classes beginning in fall 2012.

"Lilly Endowment is making a powerful impact on the college's ability to focus on the most important work before us: building a distinctive, academically strong, mission-centered School of Pharmacy," said President Jo Young Switzer.

"This grant enhances our tools to attract exceptional faculty in a highly competitive market," said Switzer. "When accredited, the School of Pharmacy will enroll
'/>"/>

SOURCE Manchester College
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
2. Manchester Announces Availability of Chenodal(TM)
3. NicOx Naproxcinod Phase 3 Results Presented at American College of Rheumatology
4. YouthAIDS, Levis and BETs Rap It-Up Campaign Kick Off 2007 Kick Me Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country
5. Trojan(R) and the National Sexuality Resource Centers Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health
6. Clinical Impact of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) is Subject of Symposium at 16th Annual Scientific Congress of Hong Kong College of Cardiology
7. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
8. Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
9. American College of Cardiology and Center of Excellence for Simulation Research of Western Michigan University (CESR) Partner for in situ Simulation to Improve Team Communication and Door-to-Balloon (D2B) Time
10. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
11. Quality Colonoscopy Exam Remains Best Strategy for Detection of Polyps and Cancers According to Experts From the American College of Gastroenterology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015  Eli Lilly and Company ... ) today announced that they have entered into a ... efficacy of AstraZeneca,s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, ... Receptor 2 antiangiogenic cancer medicine. The planned study will ... advanced solid tumors. The Phase I study ...
(Date:5/29/2015)... 2015 Educating the community continues to ... the Advancement of Wound Care (AAWC), which was ... AAWC,s corporate partners, the Association provides medical professionals ... AAWC website at http://aawconline.org/education-for-the-generalist/ . The portal ... links to various CME/CEU educational programs. This education ...
(Date:5/28/2015)... and HOUSTON , May 28, ... (TSX-V: EPI) today reported financial results for the second quarter ... unless specified otherwise, are expressed in Canadian dollars and in ... Summary Results ESSA recorded a net loss ... months ended March 31, 2015 (Q2-2015), compared to a net ...
Breaking Medicine Technology:Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14The Association for the Advancement of Wound Care Educates the Public 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... 2012 Allscripts (NASDAQ: MDRX) today announced that ... ™ to manage the revenue cycle for 39 affiliated providers ... integrated Allscripts Electronic Health Record (EHR) to automate ... the insights they need to deliver superior patient care. ...
... SAN FRANCISCO, Jan. 4, 2012  Practice Fusion, the ... community in the US, announced today that its ... a faster, simpler and more streamlined user experience ... technology flagged more than 7,000 deadly drug interactions ...
Cached Medicine Technology:Mammoth Hospital Selects Allscripts RCM Services 2Mammoth Hospital Selects Allscripts RCM Services 3Mammoth Hospital Selects Allscripts RCM Services 4Mammoth Hospital Selects Allscripts RCM Services 5Practice Fusion's Top-Rated e-Prescribing Software Gets a Doctor-Driven Makeover 2Practice Fusion's Top-Rated e-Prescribing Software Gets a Doctor-Driven Makeover 3
(Date:5/30/2015)... Il (PRWEB) May 30, 2015 Promising ... Clinical Oncology (ASCO) Annual Meeting 2015 show activity of ... in one case specifically against brain metastases and in ... breast cancer patients. , "I am thrilled to have ... in her early 40s. She didn't have any other ...
(Date:5/30/2015)... Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 30, 2015 ... safe, and simple procedure to lighten or stop ... risks of hysterectomy. This procedure can reduce or stop ... the lining of the uterus (the part that causes ... , About 10 million women suffer from heavy menstrual ...
(Date:5/30/2015)... One of the pervasive problems plaguing the ... available. Often, the ruralness of a location can severely ... areas feeling the crunch of a strained healthcare system, ... paying high premiums and copays, Online USA Doctors ... via the power of the internet. , ...
(Date:5/30/2015)... 30, 2015 Boston Scientific Corp. ... punitive and compensatory damages to a transvaginal mesh ... complications following implantation of the company’s Pinnacle and ... on May 28th in Delaware Superior Court, the ... after the jury found that the implants were ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 EHO offers ... Web Portal that gives hospices the ability to manage ... Because of this business model, EHO has been able ... pricing to its clients and survive among the giants ... hospice management systems three years ago, it has simplified ...
Breaking Medicine News(10 mins):Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 2Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 3Health News:Women's Excellence Now Provides NovaSure Treatment 2Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 2Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 3Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 2Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 3Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 4
... Diabetes mellitus is an independent risk factor for cardiovascular ... risk by 2-6 fold relative to nondiabetic subjects and ... mellitus patients will die of an atherosclerotic event. In ... cardiovascular disease, and so the presence of even borderline-high-risk ...
... and his colleagues from Southampton University have found a new ... of two or more genes fuse. The research team is ... common form of childhood leukemia, which is called as Acute ... to develop this genetic test. The treatment is given by ...
... Alzheimer’s disease (AD) is one of the most common forms ... the parts of the brain that control thought, memory, and ... an association between AD risk and several vitamins and have ... that total intake of folate at or above the RDA ...
... been demonstrated that our own experience is important to exhibit ... have been working hard to understand what happens in our ... action. The results of the observation show that the actions ... , ,The research points out that we understand the ...
... and vegetables can pave way for a long and healthy ... out that fruits and vegetables can cause dangerous interactions when ... the activity and toxicity of orally administered drugs. The effect ... ,One of the most studied or well documented of these ...
... approximately one in every 1,000 children and is characterized ... factors have been as causative factors for the disorder. ... the age of 16. There is no satisfactory treatment ... symptoms significantly. , ,The five most common types ...
Cached Medicine News:Health News:Feelings Of Sympathy And Empathy Dictated by Personal Experience 2Health News:Feelings Of Sympathy And Empathy Dictated by Personal Experience 3Health News:Guidelines for treatment of juvenile idiopathic arthritis formulated 2
... Inverness Medical Professional Diagnostics is a ... extensive IFA and DFA test menu that ... and STDs as well as miscellaneous conjugates ... give you a wide assortment of substrates ...
... Medical Professional Diagnostics is a leading provider ... and DFA test menu that includes kits ... as well as miscellaneous conjugates and components. ... a wide assortment of substrates and kit ...
... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
Medicine Products: